In 2011 this blog was listed as one of the top 10 blog in pharma technical information it is popular amongst the pharmacists and pharma industry professionals. We have published very important and very useful information for pharma industry professionals.

Thursday, December 22, 2022

Requirements of 21 CFR Part 820.100 corrective and preventive actions. Medical Devices

U S FDA Regulatory guidelines on corrective and preventive action in a pharmaceutical manufacturing firm. CAPA requirements of regulatory agencies.

Requirements of 21 CFR Part 820.100 corrective and preventive actions. Medical Devices.

Pharmaceutical manufacturing firms must have a well organized system to establish and maintain procedures for efficient implementation of CAPA procedures adapted to cover following areas. Evaluate processes manufacturing operations and other operations, Internal audit findings, QMS records, Market complaints, incidences, deviations, recalled batches, and system to gather information and data for potential root causes for nonconforming product or deviations or incidences. Statistical approach is required to be given to identify the repeated non-conformance, and their root causes. Analysis should be done by comparing the data gathered from the same non-conformances.

Data of all non-conformance should be gathered and statistical approach must be given to analyse the problems and root causes. Therefore, Investigation of root cause with proper focused methods is required. Identify the corrective actions and preventive actions required based on the identified root causes. Characterize the non conformance. Following could be the root causes.

Training 2) Design 3) Manufacturing, Management, change control, inferior quality material, improper documentation, testing, and maintenance.

Many pharmaceutical manufacturers use training as the root cause instead of other genuine root because which is again harmful. Therefore, proper tools must be used to investigate root causes of non conformance and market complaints.

Fish bone analysis, Brainstorming sessions, 5 why tool, you may extend a number of questions till you arrive at a justifiable answer leading to the root cause.

Verify and validate that corrective and preventive actions taken are sufficient to prevent the same non-conformance. Implement and document the changes done to eliminate the root causes of non conformance. Inform all stakeholders regarding the root cause and the actions taken to eliminate the same, train them. It is mandatory to submit the same for management review. All actions taken are required to be systematically documented with evidence.

US FDA during their inspections check how a manufacturing firm categorizes and arranges the data for investigation and evaluation for root cause and corrective and preventive actions.

Source: 

https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr=820.100

https://timesofpharma.com/handling-investigation-market-complaint-drug-product/

No comments:


What is 21 CFR Part 11, US FDA guidelines requirements of FDA compliance and CFR 21 Part 11.

What is a Site Master file of a pharmaceutical company

What is Generic Drug

What is Reference Listed Drug  ? ( RLD )

What is Pharmaceutical Equivalents

What is Pharmaceutical Alternatives

What is Therapeutic Equivalents

What are Post Market studies

Why a drug is bound to protein, What is protein binding?  What is drug absorption , distribution ?

Do Physical properties contribute to drug activity.

What is drug receptor , How a drug resistance occurs

Mechanism of drug resistance

What is drug interaction

Drug interaction, and its examples

What is first pass metabolism of a drug

What is What is 510(k) Clearances ?

What is 510(k) Clearances,

Premarket Notification for medical devices - PMN or 510(k)

What is a drug interaction

Examples of drug interactions


Antibiotic Definition and classification


Antibiotic Resistance and Antibiotic resistance mechanism

Antioxidants food supplements

Vitamin D Details on FDA cautions on accurate dosage of Vitamin D


What is an antibody? what is monoclonal and polyclonal antibodies?

Terminologies In vaccine Production

Multi stage testing of Virus vaccine production

Testing of vaccines at different stages of production

TESTING FOR ADVENTITIOUS AGENTS CELL PROPERTIES IN VIRAL VACCINE PRODUCTION

Enzyme linked immunosorbent assay ELISA

Raido Immuno assay

http://whoguideline.blogspot.com/2010/04/terminalogy-and-their-explanations.html

Pharmaceutical Aseptic Manufacturing Process Terms , Terminology and Definitions.

http://whoguideline.blogspot.com/2010/02/pharmaceutical-aseptic-manufacturing.html

Here are some articles which will be useful for you in further understanding of aspects of sterile dosage form manufacturing and regulatory affairs and good manufacturing practice in

pharmaceutical industry

Pharmaceutical Validation

Types of validations in pharmaceutical manufacturing


Requirements of documents for validation of sterilisation process

How to investigate OOS out of specification results

Determination of Phenol coefficient of a disinfectant

Sterility testing

Clean Room Classification

Time limitations in sterile pharmaceuticals processing

Aspects of validation of manufacturing process in sterile pharmaceuticals

Clinical Trials

Requirements of US FDA Inspections of Clinical Investigators of Clinical Trials

PROCEDURE OF AN INSPECTIONS OF CLINICAL TRIAL INVESTIGATOR BY US FDA HOW ARE CLINICAL INVESTIGATOR INSPECTIONS CONDUCTED?

US FDA INSPECTION OF CLINICAL INVESTIGATORS OUT OF UNITED STATES OF AMERICA

REPORTS AFTER AN INSPECTION OF A INVESTIGAOTR OF CLINICAL TRIALS

Controlling Pyrogens in injectable dosage forms

Media fill run process simulation aspects Validation of Aseptic Process and Sterilisation

New Drug Application (NDA) how to make a New Drug Application (NDA) to US FDA

Abbreviated New Drug Application (ANDA) What is ANDA , detailed information about ANDA preparation and submission to US FDA

How to make Investigational New Drug (IND) Application to US FDA

Drug applications submission to us fda Over the counter Drugs OTC drugs

BIOAVAILABILITY AND BIOEQUIVALENCE REQUIREMENTS

Electronic record in pharmaceutical manufacturing industry

Good manufacturing practice in pharmaceutical industry

Pharmaceutical industry pharmaceutical companies and FDA latest updates